-
Global COVID-19 Impact on Vaccines & Drugs Market Growth Is Mainly Attributed Due to Growing Number of People Infected With COVID-19 and Rising Funding for Vaccine Development – PMI
Technological advancements in the pharmaceutical sector comprising the development of nucleic acid vaccines that are DNA- and RNA-based, and which allow the human body to produce vaccine antigen. Such initiatives and activities are expected to support market growth to a substantial extent.
- Categories
- Coronavirus, Technology
-
Viewpoint: Why Tech Didn’t Save Us From COVID-19
America's paralysis reveals a deep and fundamental flaw in how the nation thinks about innovation.
- Categories
- Coronavirus, Finance, Health Care, Technology
-
Report: Countries, Companies Risk Billions in Race for Coronavirus Vaccine
“The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop,” said Paul Stoffels, chief scientific officer at Johnson & Johnson, which has partnered with the U.S. government on a $1 billion investment to speed development and production of its still-unproven vaccine. “If it fails,” Stoffels told Reuters, “it will be bad.”
- Categories
- Coronavirus, Health Care
- Region
- North America
-
Big Pharma’s Blindspot: Before COVID-19, Vaccine and Antiviral Research Went Neglected
Public health experts have warned for years that the world is at risk of a major pandemic, and advocates say Big Pharma showed little interest in developing vaccines — or even antibiotic and antiviral medications — until the latest outbreak offered an opportunity to rake in public funding and turn out massive profits with minimal risk.
- Categories
- Coronavirus, Health Care
-
Gates Foundation’s Efforts to Fight Coronavirus, Explained
The Gates Foundation has emerged as a leader in the coronavirus response.
- Categories
- Coronavirus
- Region
- North America
-
Viewpoint: How to Make a Faster Coronavirus Vaccine
Emergency funding, hard work and ingenuity could well result in a relatively speedy vaccine. But the amount of uncertainty in that outcome and the death toll that will mount even in a best-case scenario suggest a need for a far more ambitious intervention.
- Categories
- Coronavirus, Health Care
-
Viewpoint: A Covid-19 Vaccine Will Need Equitable, Global Distribution
Time is of the essence. The development of candidates for Covid-19 vaccines is progressing faster than that for any other pathogen in history. According to the World Health Organization (WHO), there are already two clinical trials underway and more than 50 vaccine candidates in clinical evaluation.
- Categories
- Coronavirus, Health Care
-
Gates Foundation, Wellcome, Mastercard launch $125M COVID-19 Therapeutics Accelerator
The Bill & Melinda Gates Foundation is teaming up with Wellcome and Mastercard to form the COVID-19 Therapeutics Accelerator, a $125 million effort to help find potential treatments for the coronavirus epidemic and future threats.
- Categories
- Coronavirus, Health Care
Parent Organization
